Literature DB >> 29142991

A Patient Navigation System to Minimize Barriers for Peritoneal Dialysis in Rural, Low-Resource Settings: Case Study From Guatemala.

David C Flood1, Anita N Chary1, Kirsten Austad1, Pablo Garcia1, Peter J Rohloff1.   

Abstract

Entities:  

Year:  2017        PMID: 29142991      PMCID: PMC5678837          DOI: 10.1016/j.ekir.2017.02.020

Source DB:  PubMed          Journal:  Kidney Int Rep        ISSN: 2468-0249


× No keyword cloud information.
To the Editor: As a recent editorial advocates, there is an urgent need to scale-up peritoneal dialysis in rural areas of low- and middle-income countries (LMICs). In this letter, we describe our experiences providing patient navigation and primary care coordination services for people receiving continuous ambulatory peritoneal dialysis (CAPD) in rural Guatemala. We write from the perspective of a nongovernmental health organization (NGO) that has supported rural Guatemalan patients carrying out CAPD for more than a decade.

Background: Chronic Kidney Disease in Guatemala

Guatemala is a lower- to middle-income, Latin American nation with a population of 16 million people and a growing need for rural dialysis services due to a confluence of factors. First, although the epidemiology and risk factors for chronic kidney disease (CKD) in Guatemala are not well understood, there is evidence that CKD mortality is among the highest in the Americas. The emerging entity “chronic kidney disease of nontraditional causes” may be a CKD risk factor in rural Guatemala, and regional data show that diabetic renal disease is a significant driver of population mortality. Second, approximately 40% of the population are rural indigenous Maya, a group that faces significant socioeconomic, geographic, and language barriers in accessing specialty nephrology care that is available only in urban tertiary centers. Finally, Guatemala’s population is growing and aging rapidly, greatly increasing the absolute number of people at risk for CKD.

Rural Peritoneal Dialysis in Guatemala

Nephrology care for rural Guatemalan adult patients with end-stage renal disease (ESRD), including dialysis, is primarily delivered by the National Center for Chronic Renal Disease (UNAERC). UNAERC is a public institution in Guatemala City that is legally tasked with making dialysis available to citizens. However, UNAERC has had challenges, as its funding increases have not kept up with a rapidly growing dialysis caseload. From a volume of fewer than 2000 persons receiving dialysis in 2008, UNAERC’s census had increased to 4286 total dialysis patients as of August 2016; of these, 2710 patients were enrolled in its continuous ambulatory peritoneal dialysis (CAPD) program. Per population, UNAERC’s volume helps to give Guatemala 1 of the highest peritoneal dialysis prevalence rates in Latin America and globally.11, 12 The UNAERC staff, although skilled and dedicated, are overburdened by patient volume and frustrated by frequent delays in payment of their wages. In addition, UNAERC has been subject to allegations of corruption. Care received at UNAERC is technically free of charge, with CAPD supplies delivered to rural homes throughout the country. Nonetheless, barriers still exist, and UNAERC’s dialysis enrollment rates tend to be much lower in rural highland areas with predominantly Maya indigenous populations. For example, UNAERC patients must purchase out-of-pocket all essential dialysis-related medications such as erythropoietin, iron, calcium, and antihypertensive agents, the costs of which can total more than patients’ yearly incomes. CAPD patients even from remote areas in Guatemala must travel regularly to the capital city for clinic visits or risk that dialysis supplies will be withheld; each trip might require a day or more of travel time and cost several days’ wages. Finally, one-fourth of Guatemalans are monolingual in an indigenous language, and care at UNAERC is delivered exclusively in Spanish.

Supporting capd in Rural Guatemala Through Patient Navigation and Primary Care Coordination

The authors of this letter are staff at Wuqu’ Kawoq, an NGO that is dedicated to providing health services for Mayan patients in rural Guatemala. In collaboration with UNAERC, we have supported approximately 25 rural patients carrying out CAPD in 4 different departments since 2007. Our role in the care of CAPD patients is to attenuate barriers experienced at UNAERC by providing patient navigation services and coordinating primary care (Table 1). CAPD patients are enrolled in our organization’s Complex Care Program, which gives them access to our team of patient navigators whose role combines social work, case management, interpretation, patient advocacy, and logistical coordination. Patient navigators arrange transportation from rural areas to the capital city, accompany patients to their UNAERC appointment, interpret between Mayan languages and Spanish, ensure that laboratory results and documents are in order, and advocate for patients during appointments. Elements of this program were adapted from patient navigation interventions to reduce cancer disparities in high-income settings and from accompaniment models of global health popularized by NGOs, such as Partners In Health.
Table 1

Challenges, opportunities, and solutions for support of peritoneal dialysis in rural Guatemala

ChallengesOpportunitiesSolutions
Language and literacy barriers to specialty nephrology care for indigenous Maya populationRising number of bilingual Maya indigenous social workers experienced in issues related to health advocacyLow cost of labor in GuatemalaRecruit professional Maya social workers to serve as patient navigators
Patients live in rural, difficult-to-access settingsExtensive, reliable cellular network coverageHigh mobile telephone penetration throughout countryBulk of care coordination and care monitoring provided via telephone encounters
High cost of ESRD medications such as erythropoietin, i.v. iron, and calcitriolRobust generic pharmaceutical industry in GuatemalaInstitutional formulary limited to generic drugsSubstitutions as feasible to reduce costs
Patients present late in CKD course, often with irreversible renal damageHigh-quality nephrology care, including CAPD management, available in capital cityPatient navigators coordinate transportation and provide accompaniment to link rural communities and urban referral centers
Supporting CAPD is expensive and requires long-term commitments to patientsBlended financing models are emerging in global healthCross-training of primary care staff allows for coverage of core salary obligations from general operating fundsCrowdfunding provides funding for initial investment in careGrants permit exploration of new areas of programmatic innovation

This table is adapted from Flood D, Mux S, Martinez B, et al. Implementation and outcomes of a comprehensive type 2 diabetes program in rural Guatemala. PLoS One. 2016;11:e0161152. CAPD, continuous ambulatory peritoneal dialysis; CKD, chronic kidney disease; ESRD, end-stage renal disease.

Challenges, opportunities, and solutions for support of peritoneal dialysis in rural Guatemala This table is adapted from Flood D, Mux S, Martinez B, et al. Implementation and outcomes of a comprehensive type 2 diabetes program in rural Guatemala. PLoS One. 2016;11:e0161152. CAPD, continuous ambulatory peritoneal dialysis; CKD, chronic kidney disease; ESRD, end-stage renal disease. Although CAPD patients generally visit UNAERC once every other month, our medical staff is involved in day-to-day care in a role analogous to that of primary care providers. We treat underlying diseases such as diabetes and hypertension, monitor for clinical and laboratory complications of CKD that arise between UNAERC visits, and manage any non−CKD-related health concerns in patients’ home villages. Patient navigators make frequent home visits or telephone calls to check in with CAPD patients, who also have access to our organization’s 24-hours-a-day, 7-days-a-week nursing hotline if questions arise such as concerns of peritonitis. We offer all of these services, including the provision of medicines and laboratory tests prescribed by UNAERC, free of charge. We also fund the construction of sterile dialysis rooms in patients’ homes, which, although not a direct medical cost, is an integral component of patient safety. To date, we have experienced only 1 episode of iatrogenic peritonitis among our CAPD cohort. Financing these services is a major challenge, given that CAPD patient navigation is very expensive compared to other global health interventions, and that there is limited international funding available for noncommunicable diseases. Such funding challenges prohibit us from accepting all rural ESRD patients who wish to enter our program. We budget $1800 per patient per year for new CAPD starts and approximately $500 per patient per year for ongoing cases, although this latter figure varies significantly based on an individual’s underlying comorbidities. We are unable to supply i.v. iron, calcitriol, or non−calcium-containing phosphate binders because of their cost. We dispense erythropoietin when prescribed by UNAERC; its use by fewer than 2 dozen patients (of more than 20,000 patients served each year in our organization’s clinics) accounts for 9% of our annual pharmaceutical budget.

Discussion and Future Directions

In this letter, we describe our organization’s experiences implementing a patient navigation and primary care coordination program to support rural CAPD patients in Guatemala. Our model provides a conceptually different approach from those of programs in Sri Lanka, China, and Colombia, which have deployed rural satellite offices to bring nephrology care closer to rural communities. Taken together, these types of strategies—whether accompanying rural patients to urban specialty care or bringing urban specialty care to rural patients—can be viewed as addressing the “system-level barriers” to rural dialysis described in a recent meeting report on kidney care needs in LMICs. Like the editorial by Nanayakkara et al., we urge implementers in other settings to share their clinical, programmatic, and delivery experiences with rural peritoneal dialysis in rural, resource-limited settings. Future directions of research on the topic of rural dialysis would also require better epidemiologic data, as the causes of CKD in LMICs are heterogeneous and poorly understood. In Guatemala and similar settings, further investigation into the costs of rural CAPD and the health-seeking behavior of ESRD patients is also important. Finally, although this letter does not specifically discuss Guatemala’s pediatric nephrology care programs, access to dialysis for rural children in LMICs is another critical area of future inquiry.

Disclosure

All the authors declared no competing interests.
  13 in total

1.  Global trends in rates of peritoneal dialysis.

Authors:  Arsh K Jain; Peter Blake; Peter Cordy; Amit X Garg
Journal:  J Am Soc Nephrol       Date:  2012-02-02       Impact factor: 10.121

2.  Understanding kidney care needs and implementation strategies in low- and middle-income countries: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.

Authors:  Vivekanand Jha; Mustafa Arici; Allan J Collins; Guillermo Garcia-Garcia; Brenda R Hemmelgarn; Tazeen H Jafar; Roberto Pecoits-Filho; Laura Sola; Charles R Swanepoel; Irma Tchokhonelidze; Angela Yee Moon Wang; Bertram L Kasiske; David C Wheeler; Goce Spasovski
Journal:  Kidney Int       Date:  2016-12       Impact factor: 10.612

3.  Latin American Dialysis and Transplant Registry: Experience and contributions to end-stage renal disease epidemiology.

Authors:  Ana Maria Cusumano; Guillermo Javier Rosa-Diez; Maria Carlota Gonzalez-Bedat
Journal:  World J Nephrol       Date:  2016-09-06

4.  Advancing the use and quality of peritoneal dialysis by developing a peritoneal dialysis satellite center program.

Authors:  Zongpei Jiang; Xueqing Yu
Journal:  Perit Dial Int       Date:  2010-12-30       Impact factor: 1.756

Review 5.  Patient navigation: state of the art or is it science?

Authors:  Kristen J Wells; Tracy A Battaglia; Donald J Dudley; Roland Garcia; Amanda Greene; Elizabeth Calhoun; Jeanne S Mandelblatt; Electra D Paskett; Peter C Raich
Journal:  Cancer       Date:  2008-10-15       Impact factor: 6.860

6.  Outcomes of a peritoneal dialysis program in remote communities within Colombia.

Authors:  Mauricio Sanabria; Martha Devia; Gilma Hernández; Kindar Astudillo; Carlos Trillos; Mauricio Uribe; Catalina Latorre; Astrid Bernal; Angela Rivera
Journal:  Perit Dial Int       Date:  2014-02-04       Impact factor: 1.756

7.  Chronic kidney disease in low- and middle-income countries.

Authors:  John W Stanifer; Anthony Muiru; Tazeen H Jafar; Uptal D Patel
Journal:  Nephrol Dial Transplant       Date:  2016-02-04       Impact factor: 5.992

8.  Dialysis enrollment patterns in Guatemala: evidence of the chronic kidney disease of non-traditional causes epidemic in Mesoamerica.

Authors:  Timothy S Laux; Joaquin Barnoya; Douglas R Guerrero; Marcos Rothstein
Journal:  BMC Nephrol       Date:  2015-04-14       Impact factor: 2.388

9.  Implementation and Outcomes of a Comprehensive Type 2 Diabetes Program in Rural Guatemala.

Authors:  David Flood; Sandy Mux; Boris Martinez; Pablo García; Kate Douglas; Vera Goldberg; Waleska Lopez; Peter Rohloff
Journal:  PLoS One       Date:  2016-09-01       Impact factor: 3.240

10.  Diabetes and Cause-Specific Mortality in Mexico City.

Authors:  Jesus Alegre-Díaz; William Herrington; Pablo Kuri-Morales; Jonathan R Emberson; Malaquías López-Cervantes; Louisa Gnatiuc; Raul Ramirez; Michael Hill; Colin Baigent; Mark I McCarthy; Sarah Lewington; Rory Collins; Gary Whitlock; Roberto Tapia-Conyer; Richard Peto
Journal:  N Engl J Med       Date:  2016-11-17       Impact factor: 91.245

View more
  8 in total

1.  Global Dialysis Perspective: Guatemala.

Authors:  Pablo Garcia; Vicente Sánchez-Polo
Journal:  Kidney360       Date:  2020-09-17

2.  CKD Care and Research in Guatemala: Overview and Meeting Report.

Authors:  Pablo Garcia; Carlos Mendoza; Joaquin Barnoya; Jose Monzón; Ann C Miller; Angie Aguilar-González; Julio Boj; Allan Cifuentes; Pedro Dávila; David Flood; Carolina Guzmán-Quilo; Agualuz Hernandez; Randall Lou-Meda; Eduardo Palacios; Vicente Sánchez-Polo; Regina Sosa; Peter Rohloff
Journal:  Kidney Int Rep       Date:  2020-07-02

3.  Perceptions of chronic kidney disease among at-risk adults in rural Guatemala.

Authors:  Meghna Nandi; Sophie Kurschner; Katharine Wilcox; David Flood; Carlos Mendoza Montano; Joaquin Barnoya; Peter Rohloff; Anita Chary
Journal:  Glob Public Health       Date:  2020-11-08

4.  Screening for chronic kidney disease in a community-based diabetes cohort in rural Guatemala: a cross-sectional study.

Authors:  David Flood; Pablo Garcia; Kate Douglas; Jessica Hawkins; Peter Rohloff
Journal:  BMJ Open       Date:  2018-01-21       Impact factor: 2.692

5.  Treatment of end-stage renal disease with continuous ambulatory peritoneal dialysis in rural Guatemala.

Authors:  Jillian Moore; Pablo Garcia; Peter Rohloff; David Flood
Journal:  BMJ Case Rep       Date:  2018-04-28

6.  Coronavirus Disease 2019 in Patients With End-Stage Kidney Disease on Hemodialysis in Guatemala.

Authors:  Regina Sosa; Pablo Garcia; Ever O Cipriano; Agualuz Hernández; Elmer E Hernández; Paola I Chavez; Angélica Manchinelli; Oscar A Morales; Lourdes E Flores; Hair J Romero; Yulany Raquec; Byron F Sapón; Kevin E Soch; Shuchi Anand; Vicente Sánchez-Polo
Journal:  Kidney Int Rep       Date:  2021-01-29

7.  Patient Navigation and Access to Cancer Care in Guatemala.

Authors:  David Flood; Anita Chary; Kirsten Austad; Merida Coj; Waleska Lopez; Peter Rohloff
Journal:  J Glob Oncol       Date:  2018-09

8.  Challenges in the provision of kidney care at the largest public nephrology center in Guatemala: a qualitative study with health professionals.

Authors:  David Flood; Katharine Wilcox; Andrea Aguilar Ferro; Carlos Mendoza Montano; Joaquin Barnoya; Pablo Garcia; Randall Lou-Meda; Peter Rohloff; Anita Chary
Journal:  BMC Nephrol       Date:  2020-02-28       Impact factor: 2.388

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.